← Evidence map

ArticleNucleic acids research2019

A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities.

Evangelia Kounatidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

38 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31006810